Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Nihon Chouzai Co Ltd banner

Nihon Chouzai Co Ltd
TSE:3341

Watchlist Manager
Nihon Chouzai Co Ltd Logo
Nihon Chouzai Co Ltd
TSE:3341
Watchlist
Price: 999 999.9999 JPY 25 377.71% Market Closed
Market Cap: ¥113.8B
Write Note Create Alert Ask AI

Nihon Chouzai Co Ltd
Investor Relations

NIHON CHOUZAI Co., Ltd. engages in the business of pharmaceutical industry. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 5,221 full-time employees. The company went IPO on 2004-09-17. The firm operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.

Show more
Loading
3341
Nikkei 225
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Naoto Kasai
President, CEO & Director
No Bio Available
Mr. Kazunori Ogi
Senior Executive Officer, GM of Finance Department & Director
No Bio Available
Mr. Yoshihisa Fujimoto
Senior Executive Officer, GM of Administration & General Affairs Department and Executive Director
No Bio Available
Mr. Noriaki Miyata
Senior Executive Officer & GM of Sales Promotion Department
No Bio Available
Mr. Yoshiki Kamada
Managing Executive Officer
No Bio Available
Mr. Toshiyuki Koyanagi
Senior Executive Officer, GM of Pharmaceutical Headquarters & Director
No Bio Available
Mr. Keiso Masuhara
Senior Executive Officer & GM of FINDAT Business Department
No Bio Available

Contacts

Address
TOKYO-TO
Chiyoda-ku
37F, Gran Tokyo North Tower, 1-9-1, Marunouchi
Contacts
+81368100800.0
www.nicho.co.jp
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.